The potential of heparin-induced extracorporeal ldl/fibrinogen precipitation (h.e.l.p.)-apheresis for patients with severe acute or chronic covid-19

HIGHLIGHTS

• who: Beate Roxane Jaeger from the Banaras Hindu University, India have published the article: The potential of heparin-induced extracorporeal LDL/fibrinogen precipitation (H.E.L.P.)-apheresis for patients with severe acute or chronic COVID-19, in the Journal: (JOURNAL)
• what: Rationale for H.E.L.P. apheresis Patients with acute and long COVID-19 most probably will benefit from H.E.L.P. apheresis due to the following reasons: 1.

SUMMARY

Hyperlipoproteinemia (a). What kind of approach is suitable to prevent looming acute lung failure involving microthrombi and inflammation . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.